Cargando…

Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen

BACKGROUND: A protective immune response against Hepatitis B infection can be obtained through the administration of a single viral polypeptide, the Hepatitis B surface antigen (HBsAg). Thus, the Hepatitis B vaccine is generated through the utilization of recombinant DNA technology, preferentially b...

Descripción completa

Detalles Bibliográficos
Autores principales: Lünsdorf, Heinrich, Gurramkonda, Chandrasekhar, Adnan, Ahmad, Khanna, Navin, Rinas, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142206/
https://www.ncbi.nlm.nih.gov/pubmed/21703024
http://dx.doi.org/10.1186/1475-2859-10-48
_version_ 1782208814806728704
author Lünsdorf, Heinrich
Gurramkonda, Chandrasekhar
Adnan, Ahmad
Khanna, Navin
Rinas, Ursula
author_facet Lünsdorf, Heinrich
Gurramkonda, Chandrasekhar
Adnan, Ahmad
Khanna, Navin
Rinas, Ursula
author_sort Lünsdorf, Heinrich
collection PubMed
description BACKGROUND: A protective immune response against Hepatitis B infection can be obtained through the administration of a single viral polypeptide, the Hepatitis B surface antigen (HBsAg). Thus, the Hepatitis B vaccine is generated through the utilization of recombinant DNA technology, preferentially by using yeast-based expression systems. However, the polypeptide needs to assemble into spherical particles, so-called virus-like particles (VLPs), to elicit the required protective immune response. So far, no clear evidence has been presented showing whether HBsAg assembles in vivo inside the yeast cell into VLPs or later in vitro during down-stream processing and purification. RESULTS: High level production of HBsAg was carried out with recombinant Pichia pastoris using the methanol inducible AOX1 expression system. The recombinant vaccine was isolated in form of VLPs after several down-stream steps from detergent-treated cell lysates. Search for the intracellular localization of the antigen using electron microscopic studies in combination with immunogold labeling revealed the presence of HBsAg in an extended endoplasmic reticulum where it was found to assemble into defined multi-layered, lamellar structures. The distance between two layers was determined as ~6 nm indicating that these lamellas represent monolayers of well-ordered HBsAg subunits. We did not find any evidence for the presence of VLPs within the endoplasmic reticulum or other parts of the yeast cell. CONCLUSIONS: It is concluded that high level production and intrinsic slow HBsAg VLP assembly kinetics are leading to retention and accumulation of the antigen in the endoplasmic reticulum where it assembles at least partly into defined lamellar structures. Further transport of HBsAg to the Golgi apparatus is impaired thus leading to secretory pathway disfunction and the formation of an extended endoplasmic reticulum which bulges into irregular cloud-shaped formations. As VLPs were not found within the cells it is concluded that the VLP assembly process must take place during down-stream processing after detergent-mediated disassembly of HBsAg lamellas and subsequent reassembly of HBsAg into spherical VLPs.
format Online
Article
Text
id pubmed-3142206
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31422062011-07-23 Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen Lünsdorf, Heinrich Gurramkonda, Chandrasekhar Adnan, Ahmad Khanna, Navin Rinas, Ursula Microb Cell Fact Research BACKGROUND: A protective immune response against Hepatitis B infection can be obtained through the administration of a single viral polypeptide, the Hepatitis B surface antigen (HBsAg). Thus, the Hepatitis B vaccine is generated through the utilization of recombinant DNA technology, preferentially by using yeast-based expression systems. However, the polypeptide needs to assemble into spherical particles, so-called virus-like particles (VLPs), to elicit the required protective immune response. So far, no clear evidence has been presented showing whether HBsAg assembles in vivo inside the yeast cell into VLPs or later in vitro during down-stream processing and purification. RESULTS: High level production of HBsAg was carried out with recombinant Pichia pastoris using the methanol inducible AOX1 expression system. The recombinant vaccine was isolated in form of VLPs after several down-stream steps from detergent-treated cell lysates. Search for the intracellular localization of the antigen using electron microscopic studies in combination with immunogold labeling revealed the presence of HBsAg in an extended endoplasmic reticulum where it was found to assemble into defined multi-layered, lamellar structures. The distance between two layers was determined as ~6 nm indicating that these lamellas represent monolayers of well-ordered HBsAg subunits. We did not find any evidence for the presence of VLPs within the endoplasmic reticulum or other parts of the yeast cell. CONCLUSIONS: It is concluded that high level production and intrinsic slow HBsAg VLP assembly kinetics are leading to retention and accumulation of the antigen in the endoplasmic reticulum where it assembles at least partly into defined lamellar structures. Further transport of HBsAg to the Golgi apparatus is impaired thus leading to secretory pathway disfunction and the formation of an extended endoplasmic reticulum which bulges into irregular cloud-shaped formations. As VLPs were not found within the cells it is concluded that the VLP assembly process must take place during down-stream processing after detergent-mediated disassembly of HBsAg lamellas and subsequent reassembly of HBsAg into spherical VLPs. BioMed Central 2011-06-26 /pmc/articles/PMC3142206/ /pubmed/21703024 http://dx.doi.org/10.1186/1475-2859-10-48 Text en Copyright ©2011 Lünsdorf et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lünsdorf, Heinrich
Gurramkonda, Chandrasekhar
Adnan, Ahmad
Khanna, Navin
Rinas, Ursula
Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen
title Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen
title_full Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen
title_fullStr Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen
title_full_unstemmed Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen
title_short Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen
title_sort virus-like particle production with yeast: ultrastructural and immunocytochemical insights into pichia pastoris producing high levels of the hepatitis b surface antigen
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142206/
https://www.ncbi.nlm.nih.gov/pubmed/21703024
http://dx.doi.org/10.1186/1475-2859-10-48
work_keys_str_mv AT lunsdorfheinrich viruslikeparticleproductionwithyeastultrastructuralandimmunocytochemicalinsightsintopichiapastorisproducinghighlevelsofthehepatitisbsurfaceantigen
AT gurramkondachandrasekhar viruslikeparticleproductionwithyeastultrastructuralandimmunocytochemicalinsightsintopichiapastorisproducinghighlevelsofthehepatitisbsurfaceantigen
AT adnanahmad viruslikeparticleproductionwithyeastultrastructuralandimmunocytochemicalinsightsintopichiapastorisproducinghighlevelsofthehepatitisbsurfaceantigen
AT khannanavin viruslikeparticleproductionwithyeastultrastructuralandimmunocytochemicalinsightsintopichiapastorisproducinghighlevelsofthehepatitisbsurfaceantigen
AT rinasursula viruslikeparticleproductionwithyeastultrastructuralandimmunocytochemicalinsightsintopichiapastorisproducinghighlevelsofthehepatitisbsurfaceantigen